Cell Biotech Co. Ltd (049960) — Cash Flow Quality Index
Cell Biotech Co. Ltd (049960) has a Cash Flow Quality Index of 1.20x as of September 2025. Operating cash flow of ₩4.15 Billion exceeds net income of ₩3.45 Billion, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of Cell Biotech Co. Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cell Biotech Co. Ltd Cash Flow Quality Index (2011–2024)
Historical Cash Flow Quality Index for Cell Biotech Co. Ltd across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Cell Biotech Co. Ltd (049960) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Cell Biotech Co. Ltd (2011–2024)
Year-by-year earnings quality comparison for Cell Biotech Co. Ltd. For live market cap and the full company financial profile, see 049960 company net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.27x | ₩19.27 Billion | ₩15.13 Billion | ▲ +2.7% |
| 2023 | 1.24x | ₩7.82 Billion | ₩6.30 Billion | ▼ -19.9% |
| 2022 | 1.55x | ₩12.81 Billion | ₩8.28 Billion | ▲ +7.9% |
| 2021 | 1.43x | ₩14.89 Billion | ₩10.38 Billion | ▼ -52.2% |
| 2020 | 3.00x | ₩9.56 Billion | ₩3.19 Billion | ▲ +112.0% |
| 2019 | 1.41x | ₩10.23 Billion | ₩7.23 Billion | ▲ +96.2% |
| 2018 | 0.72x | ₩13.98 Billion | ₩19.38 Billion | ▼ -41.8% |
| 2017 | 1.24x | ₩22.53 Billion | ₩18.20 Billion | ▲ +27.2% |
| 2016 | 0.97x | ₩17.99 Billion | ₩18.48 Billion | ▼ -6.8% |
| 2015 | 1.04x | ₩18.24 Billion | ₩17.46 Billion | ▲ +9.7% |
| 2014 | 0.95x | ₩9.91 Billion | ₩10.40 Billion | ▼ -17.4% |
| 2013 | 1.15x | ₩8.99 Billion | ₩7.80 Billion | ▲ +14.7% |
| 2012 | 1.00x | ₩6.17 Billion | ₩6.14 Billion | ▼ -4.2% |
| 2011 | 1.05x | ₩5.45 Billion | ₩5.20 Billion | — |